Research Newsletter - April/May 2023

First SAM@Simon cohort announced

The cancer center’s Office of Diversity, Equity, and Inclusion has announced the inaugural Strategy and Management Succession program (SAM@Simon) cohort.  

The 2023 SAM@Simon cohort is: 

  • Julian Marin Acevedo, M.D., assistant professor of clinical medicine, IU School of Medicine
  • Sara Bourff, MPH, vice chair of clinical and academic administration IU School of Medicine
  • Suparna Clasen, M.D., MSCE., FACC, assistant professor of clinical medicine, IU School of Medicine
  • Mario Contreraz, MBA, MSN, R.N., director of operations, Clinical Trials Office, IU Simon Comprehensive Cancer Center
  • Felicia Kennedy, research analyst, IU School of Medicine
  • Jennifer King, M.D., assistant professor of clinical medicine, IU School of Medicine
  • Kathi Ridley-Merriweather, MA, communications, recruitment, and outreach manager, Komen Tissue Bank at IU Simon Comprehensive Cancer Center
  • Christopher Njeh, Ph.D., associate professor of radiation oncology, IU School of Medicine
  • Lauren Roland, program management specialist, IU Simon Comprehensive Cancer Center
  • Pratibha Singh, Ph.D., MSC, assistant professor of pediatrics, IU School of Medicine
  • Melissa Trowbridge, research analyst, IU School of Medicine
  • Anita Turk, M.D., assistant professor of clinical medicine, IU School of Medicine

The SAM@Simon program is an intellectually rigorous, immersive, and highly experiential leadership development and succession planning program for cancer center members and affiliates to strengthen their strategic prowess. The program involves a two-day, off-campus retreat and an asynchronous four-week program

This program will accelerate participants’ careers with an in-depth understanding of the core concepts that drive academic cancer centers. Although this program is specifically designed for women and underrepresented physicians, staff, and scientists, it is open to all. 

Applications for the fall 2023 cohort are accepted on a rolling basis.

Submit a Nomination

Self-nominations also are accepted. 

Nominee Eligibility:

  • Current cancer center member or affiliation
  • Supports a core (shared facility) or involved in a research program (TMM, CPC, HHM, or EDT)
  • A letter of support from your sponsor
  • An outstanding member that displays talents, skills, and abilities for leadership 

Questions? Contact Daenique Jengelley, Ph.D., or Antwione Haywood, Ph.D.

Upcoming events

The next Simon Says Expert Series will be at noon May 31, focused on melanoma. Karl Bilimoria, M.D., will present and Lawrence Mark, M.D., will serve as moderator. Register now.  

The Review and Interpretation of the 2023 ASCO Meeting will be Saturday, July 15. This program will provide participants with the latest information presented at the 2023 American Society of Clinical Oncology (ASCO) meeting. Oncology/hematology faculty members from IU School of Medicine and the cancer center will provide participants with analysis of the more clinically applicable presentations at this year's ASCO meeting. Register now.

Member headlines and highlights

Santosh Kumar Pasupuleti, PhD
Susan Storey, PhD, RN

Santosh Kumar Pasupuleti, Ph.D. (HHM), and Reuben Kapur, Ph.D. (HHM), were among the researchers to identify a promising combination of drugs to treat juvenile myelomonocytic leukemia, a rare form of blood cancer that affects children. Learn more in this IUSM blog post.

Susan Storey, Ph.D., RN (CPC), was the primary author of the poster, The Experience of Peripheral Neuropathy Symptoms in Breast Cancer Survivors with Type 2 Diabetes, presented at Oncology Nursing Society Congress, April 26-30 in San Antonio.

Elizabeth Yeh, Ph.D. (EDT), received the Trustees Teaching Award, established by IU’s Board of Trustees. This award honors faculty who have positively impacted student learning, especially undergraduates.

Kathy Miller, M.D. (EDT), Harikrishna Nakshatri, Ph.D. (TMM), and Bryan Schneider, M.D. (CPC), have been appointed by Susan G. Komen to serve as advisors to the organization. They and six other medical and research experts will be part of a distinguished group, known as Komen Scholars, who will help guide Komen’s research and scientific programs. Read the announcement.

Rafat Abonour, M.D. (HHM), and Attaya Suvannasankha, M.D. (HHM), were leading speakers for the HealthTree Myeloma Round Table, a patient education event on April 22 in Indianapolis.

Tarah Ballinger, M.D. (CPC), was a guest on the Heroes Foundation's Summits podcast. She shared the supportive oncology programs offered by the IU Simon Comprehensive Cancer Center and the important correlations between physical activity and cancer care. Watch on YouTube.